Relatlimab drug page Clinical trials

Trials with Relatlimab

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

3Trials
1Recruiting
13Countries
7.905Planned patients
All 3 Recruiting 1 Ongoing, not recruiting 1 Finished 1
Phase All Phase 1 1 Phase 2 2

Showing 1–3 of 3

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Recruiting Phase 1 1.394 patients NCT05176483

This is a multicenter Phase 1b, open label, dose-escalation and cohort-expansion study, evaluating the safety, tolerability, pharmacokinetics (PK), preliminary antitumor activity, and effect of biomarkers of zanzalintinib administered alon…

United States, Australia, Austria, Belgium and 7 more Dec 2021 – Jun 2030 Interventional
Combined with: DocetaxelIpilimumabNivolumabPrednisoneZanzalintinib
See the trial ClinicalTrials.gov Am I eligible?
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Ongoing, not recruiting Phase 2 6.452 patients NCT02465060

This phase II MATCH screening and multi-sub-trial studies how well treatment that is directed by genetic testing works in patients with solid tumors, lymphomas, or multiple myelomas that may have spread from where it first started to nearb…

United States, Guam, Puerto Rico Aug 2015 – Dec 2026 Interventional
Combined with: AdavosertibAfatinibBinimetinibCapivasertibCopanlisibCrizotinib
See the trial ClinicalTrials.gov Am I eligible?
Study of Nivolumab and Relatlimab in Patients With Microsatellite Stable (MSS) Advanced Colorectal Cancer
Finished Phase 2 59 patients NCT03642067

The purpose of this study is to evaluate the safety and clinical activity of nivolumab and relatlimab in patients with metastatic or locally advanced microsatellite stable (MSS) colorectal cancer.

United States Feb 2019 – Sept 2024 Interventional
Combined with: Nivolumab
See the trial ClinicalTrials.gov Am I eligible?

Where the recruiting trials are